- Posted on: 05/09/2011
- Deadline : 17/01/2016
- Active users : 1407
Biosimilars and Biogenerics
Vaccine immunogens (inc. VLPs, conjugates, etc)
Description of the technology
Our inexpensive service allows you to rapidly evaluate the functions and quality of your desired recombinant protein, vaccine antigen, diagnostic reagent, therapeutic or rMAb protein expressed in hen eggs using a non GMO process.
New and innovative aspects
Each egg acts as a miniature bioreactor expressing your recombinant protein. We can express large numbers of protein variants or your other constructs rapidly and efficiently with our basic 3-step approach:
1. DESIGN the molecule, constructs, and expression strategy in order to maximise probability of a bioactive product that will meet your goals for structure, function, immunogenicity, enzymic activity, and ease of purification. Time: 2 weeks
2. Using the coding sequence (CDS) DNA for your desired product (or we can synthesize it for you), AdCEV™ DNA vector CONSTRUCTs are made. A full array of technologies ( foldons, tags, codon optimization, etc) can be incorporated in the construction of vectors to optimally express your molecule. Time: 4-6 weeks
3. We supply you with samples that can be examined by SDS PAGE, Western Blotting, RID, HI or any other assay as a first step in characterization. We can deliver material to you for testing.
Production of protein in eggs can be done with 2 eggs or 2000 eggs depending on your needs! Scale-up is simply a matter of using more eggs! Time:2-4 weeks
We offer genetic design services to improve your DNA, RNA or Protein molecular product. We rapidly design safe, effective bioproducts using our Computer Aided Gene Engineering (CAGE™) approach to create a new or improved biopharmaceutical product. We can support your vaccine or biologic product development all the way to full scale GMP manufacturing in eggs. We share the benefits of our international business and scientific experience through Consulting Services. Let us connect you to our network of knowledgeable individuals, and specialized companies, and help you enter the rapidly emerging arena of Global Health. Working with eggs offers easy scale-up, competitive yields, biosafety of your recombinant vaccine, biosimilar, diagnostic, rMAb etc. and potentially easy path to commercialization.
Our AdCEV™/ Egg production platform uses fertilized hen eggs as a biological substrate for recombinant protein production. Working with eggs offers easy scale-up, competitive yields, and easy deployment as a small, medium, or large-scale Poultry Pharm™ solutions.
Expressing your protein with AdCEV™ Vectors can provide an inexpensive way to produce milligram amounts of recombinant protein per egg in a production system that offers many attractive benefits including:
-- Rapid cloning and expression.
-- Potential for nilligrams of protein/egg.
-- Short production time- 72 h.
-- High fidelity eukaryotic post-translational processing.
-- Simplified purification from allantoic fluid.
-- Easy, rapid scale-up. with high level of biosafety for commercialization.
You can rely on decades of vaccine manufacturing experience with eggs.
Main advantages of its use
Rapid cloning and expression, Potential for nilligrams of protein/egg, Short production time- 72 h, High fidelity eukaryotic post-translational processing, Simplified purification from allantoic fluid, Easy, rapid scale-up. with high level of biosafety.
Additional information (attached documents)
Current development status
Commercially available technologies
Desired business relationship
Technology selling, Patent licensing, Joint ventures, New technology applications, Adaptation of technology to other markets
About the vendor organization
AfriVax, Inc. is a U.S.A. corporation that researches, develops, and manufactures biopharmaceutical and biological products. The company's mission is to develop safe, efficacious vaccine, diagnostic, and therapeutic products to aid in the fight against global threats to human and animal health. Our mission is to make life-saving biomedical products and services easier to develop and manufacture anywhere in the world.
Technology from AfriVax, Inc.
Related Techs for Sale:
Techs for sale related to Diagnostic equipment :
Telemedicine: new family of software products for capture, share and review of any kind of medical image in cardiology, ophthalmology, dermatology or radiologyInnovation of CLUSTER4EYE The Ophthalmology and Vision Sciences Cluster / United States
New kit for the prediction of response to treatment of patients with chronic hepatitis type genotype 1: bitherapy or triple therapyInnovation of Andalusian Public Health System Technology Transfer Office / United States
Method and kit for the prognosis of fulminant liver failure in patients with liver damage induced by drugsInnovation of Andalusian Public Health System Technology Transfer Office / United States
Classifying & registration software of dynamic contrast enhanced medical images to significantly improve image analysis and thus better help clinical diagnosisInnovation of SATT Sud Est / United States
Techs for sale related to Protein Engineering :
siRNA and their use in methods and compositions for the treatment and/or prevention of eye conditionsInnovation of CLUSTER4EYE The Ophthalmology and Vision Sciences Cluster / United States
Techs for sale related to Veterinary Medicine :
A novel vaccine to combat Paratuberculosis (Johne's Disease) in ruminant animals.Our live-attenuated vaccine technology promotes earlier & stronger immune response, eliminates bacterial shedding & side effects for better overall protection.Innovation of Pan Genome Systems Inc. / United States
Techs for sale related to Animal health :
Techs for sale related to Veterinary Medicine :
Vaccine production: Preparation of attenuated RNA viruses and production by Infectious-Subgenomic-Amplicons (ISA)Innovation of SATT Sud Est / United States
Development of fluorescencent quantitative immunochromatography strip tests for human and animal health, food safety and environmental quality analysisInnovation of Gaiker, Technological Centre / United States
Novel antimicrobial activity of chicken NK-2 peptide against apicomplexan protozoa : can be used to intervene and treat economically costly infection in the animal industryInnovation of USDA, Agricultural Research Service / United States
About techs for sale
This is a Tech for Sale. A Tech for Sale is the way Innoget clients promotes an innovative product, technology, method, process or service to get business and technology partners to contact them. Professionals like you can contact them if the product or technology is of your interest
Innoget is an open innovation marketplace for selling and buying technologies and knowledge. A global community comprised of thousands of professionals who have free access to Tech calls and Techs for sale posted by Innoget clients. Our clients are international organizations (companies and research centers.) convinced of the need to collaborate with external partners and actively seek to invest in joint development, technology acquisition, licensing or any other type of collaboration (open innovation). Via innoget.com our clients connect with companies, research institutions and innovation professionals worldwide. Organizations seeking innovation meet innovation-generating organizations. They capture external knowledge via publication of Tech calls and promote the knowledge generated within their organizations via publication of Techs for sale. By knowledge we understand innovative technologies, products, methods, procedures and services. The transfer of information is done confidentially between tech seekers and tech providers through the website. It is based on the information exchanged here that they decide to mantain contact offline